Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Comparing the Efficacy of 8 Weeks Treatment of Cipram® and its Generic Citalopram in Patients With Mixed Anxiety-Depressive Disorder

Hasan Khoonsari 1 , Mohammad Bagher Oghazian 1 , Mona Kargar 2 , Mahdiyeh Moin 3 , Hossein Khalili 1 , Abbas Alimadadi 4 , Hassan Torkamandi 5 and Padideh Ghaeli 6 , *
Authors Information
1 Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IR Iran
2 Research Center for Rational Use of Drugs, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Psychiatry, Roozbeh Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
4 University of Applied Science and Technology, Tehran, IR Iran
5 Pharmaceutical Care Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
6 Psychiatry and Psychology Research Center, Faculty of Pharmacy, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 28, 2015, 9 (2)
  • Published Online: June 23, 2015
  • Article Type: Original Article
  • Received: February 1, 2014
  • Revised: November 6, 2014
  • Accepted: November 28, 2014
  • DOI: 10.17795/ijpbs230

To Cite: Khoonsari H, Oghazian M B, Kargar M, Moin M, Khalili H, et al. Comparing the Efficacy of 8 Weeks Treatment of Cipram® and its Generic Citalopram in Patients With Mixed Anxiety-Depressive Disorder, Iran J Psychiatry Behav Sci. 2015 ; 9(2):-. doi: 10.17795/ijpbs230.

Abstract
Copyright © 2015, Mazandaran University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Kara S, Yazici KM, Gulec C, Unsal I. Mixed anxiety-depressive disorder and major depressive disorder: comparison of the severity of illness and biological variables. Psychiatry Res. 1971; 94(1): 59-66[PubMed]
  • 2. Balestrieri M, Isola M, Quartaroli M, Roncolato M, Bellantuono C. Assessing mixed anxiety-depressive disorder. A national primary care survey. Psychiatry Res. 2010; 176(2-3): 197-201[DOI][PubMed]
  • 3. International Statistical Classification of Diseases and Related Health Problems 10th Revision. 2010;
  • 4. Spijker J, Batelaan N, de Graaf R, Cuijpers P. Who is MADD? Mixed anxiety depressive disorder in the general population. J Affect Disord. 2010; 121(1-2): 180-3[DOI][PubMed]
  • 5. Carrasco JL, Diaz-Marsa M, Saiz-Ruiz J. Sertraline in the treatment of mixed anxiety and depression disorder. J Affect Disord. 2000; 59(1): 67-9[PubMed]
  • 6. Chen Y, Kelton CM, Jing Y, Guo JJ, Li X, Patel NC. Utilization, price, and spending trends for antidepressants in the US Medicaid Program. Res Social Adm Pharm. 2008; 4(3): 244-57[DOI][PubMed]
  • 7. Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, et al. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med. 2008; 149(10): 734-50[PubMed]
  • 8. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27(1): 85-102[PubMed]
  • 9. Shimatani T, Inoue M, Kuroiwa T, Xu J, Mieno H, Tazuma S. Acid-suppressive effects of generic omeprazole: comparison of three brands of generic omeprazole with original omeprazole. Dig Liver Dis. 2006; 38(8): 554-9[DOI][PubMed]
  • 10. Valles JA, Barreiro M, Cereza G, Ferro JJ, Martinez MJ, Escriba JM, et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy. 2003; 65(3): 269-75[PubMed]
  • 11. Chua GN, Hassali MA, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy. 2010; 95(2-3): 229-35[DOI][PubMed]
  • 12. Simoens S. Developing competitive and sustainable Polish generic medicines market. Croat Med J. 2009; 50(5): 440-8[PubMed]
  • 13. Citalopram.
  • 14. Management of Drugs at Health Centre Level - Training Manual. 2004;
  • 15. Citalopram. 2012;
  • 16. Diagnostic and statistical manual of mental disorders. 2000;
  • 17. Finley PR, Lee KC. Koda-Kimble and Young's Applied Therapeutics: The clinical Use of Drugs. 2013; : 1949-82
  • 18. Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther. 2003; 25(11): 2875-90[PubMed]
  • 19. Trade, foreign policy, diplomacy and health: Generic Drugs. 2011;
  • 20. Generic Drugs: Questions and Answers.
  • 21. Go CL, Rosales RL, Schmidt P, Lyons KE, Pahwa R, Okun MS. Generic versus branded pharmacotherapy in Parkinson's disease: does it matter? A review. Parkinsonism Relat Disord. 2011; 17(5): 308-12[DOI][PubMed]
  • 22. Wilner AN. Therapeutic equivalency of generic antiepileptic drugs: results of a survey. Epilepsy Behav. 2004; 5(6): 995-8[DOI][PubMed]
  • 23. Mofsen R, Balter J. Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation. Clin Ther. 2001; 23(10): 1720-31[PubMed]
  • 24. Bautista RE, Gonzales W, Jain D. Factors associated with poor seizure control and increased side effects after switching to generic antiepileptic drugs. Epilepsy Res. 2011; 95(1-2): 158-67[DOI][PubMed]
  • 25. Yu BP, Chong YS, Maguire GA. Is generic fluoxetine effective? J Affect Disord. 2004; 81(2): 185-6[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments